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Introduction
The present article outlines the basic principles of evidence-
based medicine (EBM) and how they should guide clinical
practice. Criteria by which items of evidence are judged and
the hierarchy of levels of evidence will be reviewed. The
evidence supporting a selection of commonly discussed
‘perioperative medicine’ interventions will be presented and
will then be assessed using these objective criteria. The
physiological rationale and scientific basis for these
interventions will not be discussed in detail.
Evidence-based medicine
EBM is “the integration of best research evidence with
clinical expertise and patient values to optimise clinical
outcomes and quality of life” [1]. There is often tension
between empiricism and EBM: the ‘knowledge’ of
practitioners gained from ‘experience’ may not agree with the
results of an EBM approach to clinical practice [1]. As
physicians we recognise that there is an element of art in the
practice of medicine. We must also recognise, however, that
data derived from rigorous clinical experiments should be
more compelling than personal anecdote.
When considering preventative and therapeutic interventions
a hierarchy of levels of evidence exists from the highest
standard (systematic reviews and large randomised
controlled trials [RCTs]), to the lowest level (consensus
statements and expert opinion) (see Table 1 for levels of
evidence in relation to therapeutic interventions). [2,3].
Clinical practice should, where possible, be guided by Level
1 evidence. In some cases, however, it is not possible to
obtain this level of evidence for particular interventions; for
example, when conducting the relevant trial would require
excessive resources or would be considered unethical. In this
situation the highest available standard of evidence should be
used (see Table 1).
The well-conducted RCT is the most robust and reliable
experimental methodology for comparing preventative and
therapeutic clinical interventions. RCTs are designed to
demonstrate that any observed differences in outcome
between patients allocated to different interventions (A
versus B, or A versus control) occur not simply as a result of
chance, and that bias is minimised. To this end, RCT design
frequently involves blinding of some or all of the involved
parties (investigators, patients, carers) to allocation of
treatment until after the study is complete. The aim of blinding
is to reduce the risk of unrecognised bias being introduced
by participants when they are aware of intervention allocation.
A RCT is commonly held to be ‘large’ if it includes at least
1000 patients [4]; few studies in the perioperative setting
come close to meeting this criterion.
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Abstract
The present article outlines the basic principles of Evidence Based Medicine (EBM) and how they
should guide clinical practice. The evidence supporting a selection of perioperative interventions is
assessed against objective criteria. Many of the perioperative interventions that have been widely
adopted into clinical practice are supported by very limited evidence. Conversely a high level of
evidence supports other interventions that have not been so widely adopted. This may be due to
concerns about limitations in the design and conduct of  some of the clinical trials.
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Systematic reviews or overviews are an attempt to avoid the
subjective approach of classical narrative review where authors
use self-selected references to support an established
argument. A well-conducted systematic review should have the
following elements: a clearly framed question or objective, the
use of an appropriate methodology to search for all relevant
literature, and a systematic approach to study selection,
assessment of study quality, data extraction and data analysis.
Meta-analysis is the use of quantitative methods to summarise
the results of a systematic review [5]. Systematic reviews have
a useful role both in quantitative pooling of data using the
techniques of meta-analysis and by providing qualitative
summaries of original reports in a specific area.
Objective methods exist for quality assessment of studies
[6,7], and this is an important element of the systematic
review process. The old adage ‘rubbish in, rubbish out’
succinctly summarises the futility of performing a meta-
analysis of poor quality studies and then imbuing the
summary statistic with any significance. The inclusion of ‘poor
quality’ studies may bias the results of systematic reviews [6].
Heterogeneity reduces the validity of the result of a
systematic review. This heterogeneity can be clinical (e.g.
variations in the intervention or setting) or can be statistical
(e.g. variations in the outcomes suggesting that the studies
may not having been addressing the same question) [5].
Evidence of heterogeneity suggests that it may be
inappropriate to group together the selected studies.
When assessing preventative or therapeutic interventions
the best evidence may be provided by a systematic review of
all relevant RCTs. However a systematic review of older,
smaller or weaker studies, or demonstrating significant
heterogeneity, may be inferior to a large well conducted and
generisable RCT.
Founded in 1993, the Cochrane Collaboration is an
international, independent, nonprofit organisation that
produces and disseminates systematic reviews of healthcare
interventions, and promotes the search for evidence in the
form of clinical trials and other studies of interventions
(http://www.cochrane.org/index0.htm). The major product of
the collaboration is the Cochrane Database of Systematic
Reviews, published quarterly as part of the Cochrane Library
(http://www.cochrane.org/reviews/clibintro.htm). The Cochrane
Anaesthesia Review Group (http://www.cochrane-
anaesthesia.suite.dk/) is one of the many subject-specific
collaborative review groups affiliated to the Cochrane
Collaboration, and includes within its scope anaesthesia,
perioperative medicine, intensive care medicine, prehospital
medicine, and resuscitation and emergency medicine.
Reviews conducted under the auspices of the Cochrane
Collaboration use a clearly defined methodology, and external
peer review is integral to each stage of the review process.
Meta-analyses may be subject to bias in the same way as
individual RCTs. Publication bias, English-language bias,
citation bias, multiple publication bias, database bias and
study inclusion bias are recognised and are covered in detail
elsewhere [8]. Specific tests for assessing bias are available
(e.g. Funnel plot for publication bias) [9,10]. Reviews
published by the Cochrane Collaboration seem to show less
evidence of bias (13% versus 38% of reviews studied) than
systematic reviews selected at random from major journals [9].
Large RCTs and systematic reviews may disagree, and this
occurs at a rate greater than chance alone would predict.
Table 1
Levels of evidence for therapeutic interventions
Level of evidence Therapy/prevention, aetiology/harm
1 A Systematic review (with homogeneity*) of randomised controlled trials
B Individual randomised controlled trial (with narrow confidence interval)
C All or none
2 A Systematic review (with homogeneity) of cohort studies
B Individual cohort study (including low-quality randomised controlled trial [e.g. < 80% follow-up])
C ‘Outcomes’ research; ecological studies
3 A Systematic review (with homogeneity*) of case–control studies
B Individual case–control study
4 Case series (and poor-quality cohort and case–control studies)
5 Expert opinion without explicit critical appraisal, or based on physiology, bench research or ‘first principles’
Modified from [http://www.cebm.net/levels_of_evidence.asp]. *By homogeneity we mean a systematic review that is free of worrisome variations
(heterogeneity) in the directions and degrees of results between individual studies. Not all systematic reviews with statistically significant
heterogeneity need be worrisome, and not all worrisome heterogeneity need be statistically significant.83
When both the magnitude and uncertainty of treatment
effects were considered, large trials disagreed with meta-
analyses in 10–23% of cases [4].
Perioperative interventions and EBM?
We have chosen to consider a subjectively generated list of
perioperative interventions commonly considered to be
elements of the practice of the anaesthetist or the perioperative
physician. For each intervention we describe the extent of the
supporting literature (RCTs and systematic reviews), the level
of evidence and the outcome supported (mortality, length of
stay, morbidity). We have searched PubMed (http://www.ncbi.
nlm.nih.gov/entrez/query.fcgi?db=PubMed), the Cochrane
Library (http://www.cochrane.org/reviews/clibintro.htm) and the
internet based "Evidence-based Perioperative Medicine"
resource (http://www.hcuge.ch/anesthesie/anglais/evidence/
arevusyst.htm) for systematic reviews and RCTs. Where there
are more than 10 RCTs addressing a particular question we
have not listed them separately.
Table 2 summarises the evidence (RCTs and systematic
reviews) supporting each listed intervention.  However due
to limitations in the design and conduct of these studies
there is considerable controversy amongst professionals that
care for patients in the perioperative setting as to whether
some of these interventions are as effective as the data
suggest.
‘Optimisation’
The observation that patients who survive major surgery have
elevated cardiac output and oxygen delivery values led to the
development of goal-directed therapy, otherwise known as
haemodynamic optimisation. Cardiac output and oxygen
delivery are augmented by the administration of intravenous
fluids, with or without the addition of inotropic agents such as
dobutamine or dopexamine. A treatment algorithm guided by
haemodynamic monitoring drives therapy. Treatment goals
are often supranormal values of blood-flow-related variables
(e.g. cardiac index, oxygen delivery, stroke volume).
Two systematic reviews with meta-analyses studying this
strategy in the perioperative setting have concluded that
mortality is reduced using this approach [11,12]. The first
review showed a significant reduction in mortality if therapy
was initiated preoperatively (two trials, 195 patients). The
second review of 21 trials (13 perioperative trials, >1008
patients) revealed significant mortality reduction when
patients were treated before the development of organ
failure, when there were control group mortalities >20% and
when therapy produced differences in oxygen delivery
between the control and protocol groups [12]. An additional
systematic review of perioperative fluid volume optimisation
following proximal femoral fracture (two studies, 130
patients) showed a reduction in the hospital length of stay in
the intervention group [13]. However, a recent large
perioperative RCT failed to show any benefit [14]. The large
RCT has been criticised on a number of design and conduct
issues, and the systematic reviews exhibit significant
heterogeneity. This is a good example of a large RCT
producing a different result from previous systematic reviews.
Beta-adrenergic receptor blockade
Cardiovascular disease is an important cause of perioperative
morbidity and mortality. This is thought to be due to
sympathetic over-activity increasing heart rate, myocardial
workload and the incidence of arrhythmias. Perioperative
blockade of beta-adrenergic receptors may be protective
against cardiovascular complications such as myocardial
infarction and arrhythmias, and therefore may reduce mortality.
Three (small) randomised trials examined the use of beta-
blockers in surgical patients with known or suspected
coronary disease [15–17]. Two of these trials demonstrated
a significant reduction in mortality in the intervention group.
However, one study (200 patients undergoing elective major
noncardiac surgery) stopped beta-blockers prior to surgery in
patients in the control group who were already taking them,
and this is inconsistent with current guidelines [15]. In the
other study (112 patients presenting for elective major
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Table 2
Comparison of evidence available for a selection of commonly discussed perioperative interventions
Cochrane Large  Randomised 
systematic Systematic  randomised controlled 
Intervention review review controlled trial trial Level 1 evidence (mortality)
Optimisation 1 2 1 > 10 Yes (systematic review)
Beta-blockade 0 0 0 3 Yes (small randomised controlled trial only)
Regional anaesthesia 3 > 10 0 > 10 Yes (systematic review)
Enteral nutrition 0 2 0 > 10 No
High O2 0002 N o
Normothermia 0 0 0 4 No
Critical care  0 0 0 0 No84
vascular surgery), patients were preselected on the basis of
positive dobutamine stress echocardiograms from an initial
cohort of 1351 patients, which makes it difficult to generalise
these data to a population not selected in this manner [16]. In
the third study (107 patients undergoing elective knee
arthroplasty), a reduced prevalence and duration of
postoperative myocardial ischaemia detected with Holter
monitoring was demonstrated [17].
There are no large RCTs (>1000 patients) or systematic
reviews that demonstrate the effect of this intervention on
mortality. Nonetheless, the results of these small studies
suggest that perioperative beta-blockade improves outcome
in patients with known or suspected heart disease. The
American College of Cardiology and American Heart
Association guidelines now recommend this strategy [18]. A
large international RCT is currently being conducted to test
the hypothesis that perioperative administration of beta-
adrenergic blockers in patients with risk factors for ischaemic
heart disease reduces mortality (the ‘POISE’ study).
Regional anaesthesia/analgesia
Improved postoperative pain relief is important for patient
comfort and may decrease the hospital stay and lead to
reductions in morbidity. Improved blood flow consequent on
sympatholysis has additional potential benefits, including a
reduction in thromboembolic complications and improved
gastrointestinal function.
A large number of RCTs in this area have been summarised in
several systematic reviews with meta-analysis. Pooled analysis
of 141 randomised trials involving a total of 9559 patients
revealed a 30% reduction in mortality associated with
neuraxial blockade and significant reductions in
thromboembolic and respiratory complications [19]. Pain relief
with epidural analgesia with local anaesthetic agents has been
demonstrated to be superior to parenteral opioids alone in a
meta-analysis of 100 studies [20]. Regional anaesthesia for
hip fracture surgery when compared with general anaesthesia
produced comparable results for most of the outcomes
studied (16 trials, 2191 patients). Regional anaesthesia may
have reduced short-term mortality, but no conclusions could
be drawn for longer-term mortality [21]. For hip and knee
replacement surgery short-term postoperative pain relief was
improved with regional anaesthesia but minor complications
were more frequent, and there were insufficient data to draw
conclusions on the frequency of rare complications from
epidural analgesia, postoperative morbidity or mortality,
functional outcomes, or length of hospital stay [22]. Following
abdominal surgery, the time to return of gastrointestinal
function was reduced with epidural anaesthesia but there
were insufficient data to comment on mortality [23].
Nutrition
The concept that improving nutritional status and minimising
catabolism will improve perioperative outcome has been
tested in a large number of RCTs, and two systematic
reviews have addressed questions in this area. A systematic
review of 11 studies with 837 patients demonstrated that
early enteral feeding postoperatively after gastrointestinal
surgery reduced infection rates and the length of stay but did
not significantly reduce mortality [24]. When compared with
enteral nutrition, total parenteral nutrition does not influence
the death rate of surgical patients, but may reduce the
complication rate, especially in malnourished patients [25].
Supplemental oxygen therapy
The bactericidal activity of neutrophils is mediated by
oxidative killing by the production of superoxide radicals, the
rate of generation of which is proportional to the partial
pressure of oxygen. At surgical wound sites this is likely to be
low due to disrupted vascular supply and decreased blood
flow perioperatively. Resistance to infection may be
enhanced by the administration of supplemental oxygen to
increase tissue oxygenation and augment neutrophil function.
A moderate-sized randomised trial (500 patients undergoing
elective general surgery) in which 30% or 80% oxygen was
administered perioperatively demonstrated a reduction in
wound infection in the higher FiO2 group [26]. However, a
more recent small study of similar design found an increase in
infection in those administered the higher FiO2 [27]. There
are no RCTs or systematic reviews that demonstrate a
beneficial effect of this intervention on mortality.
Maintenance of normothermia
Inhibition of physiological temperature control mechanisms,
peripheral redistribution of body heat during general
anaesthesia and the cool operating room environment
contribute to perioperative hypothermia. Immune cell function
becomes impaired as a consequence of low tissue
oxygenation and hypothermia. Temperature reduction also
has an adverse effect on collagen deposition. These factors
have an unfavourable effect on surgical wound healing.
Four small to moderate-sized clinical studies (60–300
patients) have compared active warming (normothermia) with
the standard of care (resulting in mild hypothermia) [28–31].
In 200 patients undergoing elective colorectal surgery, those
randomised to receive active warming had a reduced
incidence of wound infection [29]. In 60 patients undergoing
primary hip arthroplasties, the postoperative blood loss and
transfusion requirements were significantly greater in the
hypothermic patients [31]. In 300 patients undergoing
abdominal, thoracic or vascular surgical procedures with
documented coronary artery disease, or risk factors for
coronary disease, perioperative cardiac events and ventricular
tachycardia occurred less frequently in the normothermic
group [28]. In 150 patients undergoing elective major
abdominal surgery, a decreased duration of postanaesthetic
recovery was observed in the normothermic group [30]. There
are no RCTs or systematic reviews that demonstrate a
beneficial effect of this intervention on mortality.
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Critical care provision
Differences in case-mix-adjusted mortality have been noted be-
tween countries where levels of critical care provision differ [32].
In a systematic review of 27 studies, high-intensity ICU
physician staffing versus low-intensity ICU physician staffing
was associated with reduced hospital and ICU mortality and
with reduced hospital and ICU length of stay [33]. No RCTs
(large or small) or systematic reviews exist to test the hypothesis
that critical provision postoperatively reduces mortality.
Conclusions
Many of the perioperative interventions that have been widely
adopted into clinical practice are supported by very limited
evidence. For a number of interventions the data are either
limited in quantity or quality, or are inconsistent. Systematic
reviews are no better than the studies that they bring
together, and those that include many small studies are often
limited by problems of heterogeneity. Systematic reviews
should be conducted with the same methodological rigour
expected for RCTs. Systematic reviews conducted under the
auspices of the Cochrane Collaboration have an established
methodology and peer review process, and they may be less
prone to bias than non-Cochrane systematic reviews.
Competing interests
The author(s) declare that they have no competing interests.
References
1. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson
WS: Evidence based medicine: what it is and what it isn’t.
BMJ 1996, 312:71-72.
2. Guyatt GH, Cook DJ, Sackett DL, Eckman M, Pauker S: Grades
of recommendation for antithrombotic agents. Chest 1998,
114(Suppl):441S-444S.
3. Levels of Evidence and Grades of Recommendation [electronic
citation]. Oxford: Oxford Centre for Evidence-Based Medicine;
2004 [http://www.cebm.net/levels_of_evidence.asp#levels].
4. Ioannidis JP, Cappelleri JC, Lau J: Issues in comparisons
between meta-analyses and large trials. JAMA 1998,  279:
1089-1093.
5. Egger M, Smith GD, Phillips AN: Meta-analysis: principles and
procedures. BMJ 1997, 315:1533-1537.
6. Schulz KF, Chalmers I, Hayes RJ, Altman DG: Empirical evi-
dence of bias. Dimensions of methodological quality associ-
ated with estimates of treatment effects in controlled trials.
JAMA 1995, 273:408-412.
7. Juni P, Altman DG, Egger M: Systematic reviews in health care:
assessing the quality of controlled clinical trials. BMJ 2001,
323:42-46.
8. Egger M, Smith GD: Bias in location and selection of studies.
BMJ 1998, 316:61-66.
9. Egger M, Davey SG, Schneider M, Minder C: Bias in meta-
analysis detected by a simple, graphical test. BMJ 1997, 315:
629-634.
10. Sterne JA, Egger M, Smith GD: Systematic reviews in health
care: investigating and dealing with publication and other
biases in meta-analysis. BMJ 2001, 323:101-105.
11. Heyland DK, Cook DJ, King D, Kernerman P, Brun-Buisson C: Max-
imizing oxygen delivery in critically ill patients: a methodologic
appraisal of the evidence. Crit Care Med 1996, 24:517-524.
12. Kern JW, Shoemaker WC: Meta-analysis of hemodynamic opti-
mization in high-risk patients. Crit Care Med 2002, 30:1686-1692.
13. Price J, Sear J, Venn R: Perioperative fluid volume optimization
following proximal femoral fracture. Cochrane Database Syst
Rev 2002, 1:CD003004.
14. Sandham JD, Hull RD, Brant RF, Knox L, Pineo GF, Doig CJ,
Laporta DP, Viner S, Passerini L, Devitt H, et al.: A randomized,
controlled trial of the use of pulmonary-artery catheters in
high-risk surgical patients. N Engl J Med 2003, 348:5-14.
15. Mangano DT, Layug EL, Wallace A, Tateo I: Effect of atenolol on
mortality and cardiovascular morbidity after noncardiac
surgery. Multicenter Study of Perioperative Ischemia. N Engl J
Med 1996, 335:1713-1720.
16. Poldermans D, Boersma E, Bax JJ, Thomson IR, van de Ven LL,
Blankensteijn JD, Baars HF, Yo TI, Trocino G, Vigna C, et al.: The
effect of bisoprolol on perioperative mortality and myocardial
infarction in high-risk patients undergoing vascular surgery.
Dutch Echocardiographic Cardiac Risk Evaluation Applying
Stress. N Engl J Med 1999, 341:1789-1794.
17. Urban MK, Markowitz SM, Gordon MA, Urquhart BL, Kligfield P:
Postoperative prophylactic administration of beta-adrenergic
blockers in patients at risk for myocardial ischemia. Anesth
Analg 2000, 90:1257-1261.
18. Eagle KA, Berger PB, Calkins H, Chaitman BR, Ewy GA, Fleis-
chmann KE, Fleisher LA, Froehlich JB, Gusberg RJ, Leppo JA, et
al.: ACC/AHA guideline update for perioperative cardiovascu-
lar evaluation. Anesth Analg 2002, 94:1052-1064.
19. Rodgers A, Walker N, Schug S, McKee A, Kehlet H, van Zundert
A, Sage D, Futter M, Saville G, Clark T, et al.: Reduction of post-
operative mortality and morbidity with epidural or spinal
anaesthesia: results from overview of randomised trials. BMJ
2000, 321:1493-1497.
20. Block BM, Liu SS, Rowlingson AJ, Cowan AR, Cowan JA, Jr, Wu
CL:  Efficacy of postoperative epidural analgesia: a meta-
analysis. JAMA 2003, 290:2455-2463.
21. Parker MJ, Urwin SC, Handoll HH, Griffiths R: General versus
spinal/epidural anaesthesia for surgery for hip fractures in
adults. Cochrane Database Syst Rev 2000, 2:CD000521.
22. Choi PT, Bhandari M, Scott J, Douketis J: Epidural analgesia for
pain relief following hip or knee replacement. Cochrane Data-
base Syst Rev 2003, 3:CD003071.
23. Jorgensen H, Wetterslev J, Moiniche S, Dahl JB: Epidural local
anaesthetics versus opioid-based analgesic regimens on
postoperative gastrointestinal paralysis, PONV and pain after.
Cochrane Database Syst Rev 2000, 4:CD001893.
24. Lewis SJ, Egger M, Sylvester PA, Thomas S: Early enteral
feeding versus ‘nil by mouth’ after gastrointestinal surgery:
systematic review and meta-analysis of controlled trials. BMJ
2001, 323:773-776.
25. Heyland DK, Montalvo M, MacDonald S, Keefe L, Su XY, Drover
JW: Total parenteral nutrition in the surgical patient: a meta-
analysis. Can J Surg 2001, 44:102-111.
26. Greif R, Akca O, Horn EP, Kurz A, Sessler DI: Supplemental
perioperative oxygen to reduce the incidence of surgical-
wound infection. Outcomes Research Group. N Engl J Med
2000, 342:161-167.
27. Pryor KO, Fahey TJ, III, Lien CA, Goldstein PA: Surgical site
infection and the routine use of perioperative hyperoxia.
JAMA 2004, 291:79-87.
28. Frank SM, Fleisher LA, Breslow MJ, Higgins MS, Olson KF, Kelly
S, Beattie C: Perioperative maintenance of normothermia
reduces the incidence of morbid cardiac events. A random-
ized clinical trial. JAMA 1997, 277:1127-1134.
29. Kurz A, Sessler DI, Lenhardt R: Perioperative normothermia to
reduce the incidence of surgical-wound infection and shorten
hospitalization. Study of Wound Infection and Temperature
Group. N Engl J Med 1996, 334:1209-1215.
30. Lenhardt R, Marker E, Goll V, Tschernich H, Kurz A, Sessler DI,
Narzt E, Lackner F: Mild intraoperative hypothermia prolongs
postanesthetic recovery. Anesthesiology 1997, 87:1318-1323.
31. Schmied H, Kurz A, Sessler DI, Kozek S, Reiter A: Mild hypother-
mia increases blood loss and transfusion requirements
during total hip arthroplasty. Lancet 1996, 347:289-292.
32. Bennett-Guerrero E, Hyam JA, Shaefi S, Prytherch DR, Sutton GL,
Weaver PC, Mythen MG, Grocott MP, Parides MK: Comparison
of P-POSSUM risk-adjusted mortality rates after surgery
between patients in the USA and the UK. Br J Surg 2003,
90:1593-1598.
33. Pronovost PJ, Angus DC, Dorman T, Robinson KA, Dremsizov TT,
Young TL: Physician staffing patterns and clinical outcomes in
critically ill patients: a systematic review. JAMA 2002,  288:
2151-2162.
Available online http://ccforum.com/content/9/1/81